SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (644)8/10/1999 5:48:00 AM
From: Mike McFarland  Read Replies (1) of 4474
 
Real pain: On May 11, 1998, the Company completed
a private placement of 2,537,500 shares of common stock
to a group of institutional investors at a price of $4.00
per share and received net proceeds of approximately
$9,226,000 after deducting selling commissions and offering
expenses.


ARIA was a $4 1/2 dollar stock back then.

The flurry of activity on the thread is a little strange,
suggests to me that something is going to happen either
way. I cant believe that you all suddenly woke up to
Ariad just now--not with me thrashing around on all the
biotech threads these past few months. Is there something
magic about a buck? Was there anything to my suggestion
that the C holders will not want to see a delisting?

The sad part is that I'm going to get stopped out of
this, and on that day a few of you will finally be
starting positions.

Saw a few papers in Nature which mention Wingless
--threw this post together for fun:
messages.yahoo.com

I see this thread made it up pretty high on the hot list
yesterday. Newbies should know that a casual interest
is exactly enough to get yourself into pretty big
trouble--I've most certainly screwed myself, and mistakes
are made to be punished.
I'm not the sharpest tool in the shed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext